Viewing Study NCT04129320


Ignite Creation Date: 2025-12-25 @ 4:29 AM
Ignite Modification Date: 2025-12-26 @ 3:32 AM
Study NCT ID: NCT04129320
Status: WITHDRAWN
Last Update Posted: 2022-02-08
First Post: 2019-10-14
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Enoblituzumab Plus MGA012 or MGD013 in Squamous Cell Carcinoma of the Head and Neck
Sponsor: MacroGenics
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module